 prospect trial adjuv chemotherapi bolu versu continu infus doxorubicin patient high-grad extrem soft tissu sarcoma analysi prognost factor prospect trial cardiotox therapeut effect doxorubicin week bolu continu infus adjuv chemotherapi elig patient resect high-grad soft tissu sarcoma extrem superfici trunk cardiac toxic decreas left ventricular eject fraction radionuclid cineangiographi patient cardiotox patient bolu treatment arm median doxorubicin dose patient continu infus cardiotox median dose rate cardiotox function cumul dose doxorubicin bolu treatment arm patient group clinic congest heart failur cardiac death trend rate metastasi rate death diseas patient bolu dose cox model analysi unfavor characterist rate distant metastasi blood transfus hour oper deep fascia cm size histolog subtyp liposarcoma unfavor effect continu infus model adjuv chemotherapi patient soft tissu sarcoma investig impact periop blood transfus studi